• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

设计、合成与评估 SARS-CoV-2 nsp3 结构域大分子抑制剂。

Design, synthesis and evaluation of inhibitors of the SARS-CoV-2 nsp3 macrodomain.

机构信息

McDaniel College, Department of Chemistry, 2 College Hill, Westminster, MD 21157, USA.

Infectious Disease Assay Development Laboratory/HTS, University of Kansas, Lawrence, KS 66047, USA.

出版信息

Bioorg Med Chem. 2022 Aug 1;67:116788. doi: 10.1016/j.bmc.2022.116788. Epub 2022 May 11.

DOI:10.1016/j.bmc.2022.116788
PMID:35597097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9093066/
Abstract

A series of amino acid based 7H-pyrrolo[2,3-d]pyrimidines were designed and synthesized to discern the structure activity relationships against the SARS-CoV-2 nsp3 macrodomain (Mac1), an ADP-ribosylhydrolase that is critical for coronavirus replication and pathogenesis. Structure activity studies identified compound 15c as a low-micromolar inhibitor of Mac1 in two ADP-ribose binding assays. This compound also demonstrated inhibition in an enzymatic assay of Mac1 and displayed a thermal shift comparable to ADPr in the melting temperature of Mac1 supporting binding to the target protein. A structural model reproducibly predicted a binding mode where the pyrrolo pyrimidine forms a hydrogen bonding network with Asp and the amide backbone NH of Ile in the adenosine binding pocket and the carboxylate forms hydrogen bonds to the amide backbone of Phe and Asp, part of the oxyanion subsite of Mac1. Compound 15c also demonstrated notable selectivity for coronavirus macrodomains when tested against a panel of ADP-ribose binding proteins. Together, this study identified several low MW, low µM Mac1 inhibitors to use as small molecule chemical probes for this potential anti-viral target and offers starting points for further optimization.

摘要

设计并合成了一系列基于氨基酸的 7H-吡咯并[2,3-d]嘧啶,以区分其针对 SARS-CoV-2 nsp3 结构域(Mac1)的结构活性关系,Mac1 是一种 ADP-核糖基水解酶,对冠状病毒的复制和发病机制至关重要。结构活性研究发现,化合物 15c 在两种 ADP-核糖结合测定中是 Mac1 的低微摩尔抑制剂。该化合物在 Mac1 的酶测定中也显示出抑制作用,并且在 Mac1 的熔点的热移位与 ADPr 相当,支持与靶蛋白结合。结构模型可重现性地预测了一种结合模式,其中吡咯并嘧啶与天冬氨酸形成氢键网络,酰胺主链 NH 与 Ile 在腺苷结合口袋中,羧基与 Phe 和 Asp 的酰胺主链形成氢键,这是 Mac1 的氧阴离子亚基的一部分。化合物 15c 在针对一组 ADP-核糖结合蛋白的测试中也表现出对冠状病毒结构域的显著选择性。总的来说,这项研究确定了几种低 MW、低 µM 的 Mac1 抑制剂,可作为该潜在抗病毒靶标的小分子化学探针,并为进一步优化提供了起点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8287/9093066/8ea21198a097/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8287/9093066/5bdbae2833bf/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8287/9093066/80b91b60b3e8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8287/9093066/aead989bd1ff/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8287/9093066/093be359f358/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8287/9093066/37d9671f2251/gr9_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8287/9093066/caa8d2044981/gr10_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8287/9093066/23e3052ed0c9/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8287/9093066/706dc5a35184/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8287/9093066/1d9bb8a1d7f6/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8287/9093066/23e951d18cf5/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8287/9093066/8ea21198a097/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8287/9093066/5bdbae2833bf/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8287/9093066/80b91b60b3e8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8287/9093066/aead989bd1ff/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8287/9093066/093be359f358/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8287/9093066/37d9671f2251/gr9_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8287/9093066/caa8d2044981/gr10_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8287/9093066/23e3052ed0c9/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8287/9093066/706dc5a35184/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8287/9093066/1d9bb8a1d7f6/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8287/9093066/23e951d18cf5/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8287/9093066/8ea21198a097/gr6_lrg.jpg

相似文献

1
Design, synthesis and evaluation of inhibitors of the SARS-CoV-2 nsp3 macrodomain.设计、合成与评估 SARS-CoV-2 nsp3 结构域大分子抑制剂。
Bioorg Med Chem. 2022 Aug 1;67:116788. doi: 10.1016/j.bmc.2022.116788. Epub 2022 May 11.
2
Design, Synthesis and Evaluation of Inhibitors of the SARS-CoV2 nsp3 Macrodomain.严重急性呼吸综合征冠状病毒2非结构蛋白3大结构域抑制剂的设计、合成与评价
bioRxiv. 2022 Feb 28:2022.02.27.482176. doi: 10.1101/2022.02.27.482176.
3
The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase.SARS-CoV-2 保守宏结构域是一种单 ADP-核糖基水解酶。
J Virol. 2021 Jan 13;95(3). doi: 10.1128/JVI.01969-20.
4
Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening.高通量筛选发现抑制 SARS-CoV-2 Mac1-ADP-ribose 结合的化合物。
Antiviral Res. 2022 Jul;203:105344. doi: 10.1016/j.antiviral.2022.105344. Epub 2022 May 19.
5
Synthesis of Structural ADP-Ribose Analogues as Inhibitors for SARS-CoV-2 Macrodomain 1.结构型 ADP-核糖类似物的合成及其作为 SARS-CoV-2 宏结构域 1 抑制剂的应用
Org Lett. 2024 Jul 12;26(27):5700-5704. doi: 10.1021/acs.orglett.4c01792. Epub 2024 Jun 27.
6
The SARS-CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)保守的大分子结构域是一种单磷酸腺苷核糖水解酶。
bioRxiv. 2020 Oct 28:2020.05.11.089375. doi: 10.1101/2020.05.11.089375.
7
Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors.利用人聚(ADP-核糖)糖苷水解酶(PARG)结构及抑制剂的见解靶向严重急性呼吸综合征冠状病毒2(SARS-CoV-2)非结构蛋白3(Nsp3)宏结构域。
Prog Biophys Mol Biol. 2021 Aug;163:171-186. doi: 10.1016/j.pbiomolbio.2021.02.002. Epub 2021 Feb 23.
8
High-Throughput Screening and Quantum Mechanics for Identifying Potent Inhibitors Against Mac1 Domain of SARS-CoV-2 Nsp3.高通量筛选和量子力学在鉴定针对 SARS-CoV-2 Nsp3 的 Mac1 结构域的有效抑制剂中的应用。
IEEE/ACM Trans Comput Biol Bioinform. 2021 Jul-Aug;18(4):1262-1270. doi: 10.1109/TCBB.2020.3037136. Epub 2021 Aug 6.
9
Mutation of a highly conserved isoleucine residue in loop 2 of several β-coronavirus macrodomains indicates that enhanced ADP-ribose binding is detrimental for replication.几种β-冠状病毒结构域环 2 中高度保守的异亮氨酸残基的突变表明,增强的 ADP-核糖结合不利于复制。
J Virol. 2024 Nov 19;98(11):e0131324. doi: 10.1128/jvi.01313-24. Epub 2024 Oct 10.
10
GS-441524-Diphosphate-Ribose Derivatives as Nanomolar Binders and Fluorescence Polarization Tracers for SARS-CoV-2 and Other Viral Macrodomains.二磷酸核糖基 GS-441524 衍生物作为 SARS-CoV-2 和其他病毒大结构域的纳摩尔结合物和荧光偏振示踪剂。
ACS Chem Biol. 2024 May 17;19(5):1093-1105. doi: 10.1021/acschembio.4c00027. Epub 2024 Apr 22.

引用本文的文献

1
Structural and functional analyses of SARS-CoV-2 Nsp3 and its specific interactions with the 5' UTR of the viral genome.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)非结构蛋白3(Nsp3)的结构与功能分析及其与病毒基因组5'非翻译区(UTR)的特异性相互作用
Microbiol Spectr. 2025 Aug 5;13(8):e0287124. doi: 10.1128/spectrum.02871-24. Epub 2025 Jul 7.
2
Exploration of structure-activity relationships for the SARS-CoV-2 macrodomain from shape-based fragment linking and active learning.基于形状的片段连接和主动学习对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)宏结构域进行构效关系探索
Sci Adv. 2025 May 30;11(22):eads7187. doi: 10.1126/sciadv.ads7187. Epub 2025 May 28.
3

本文引用的文献

1
Preparation of screening assays for ADP-ribosyl readers and erasers using the GAP-tag as a binding probe.使用 GAP 标签作为结合探针,制备 ADP-ribosyl 读取器和橡皮擦的筛选测定法。
STAR Protoc. 2022 Jan 29;3(1):101147. doi: 10.1016/j.xpro.2022.101147. eCollection 2022 Mar 18.
2
The Conserved Macrodomain Is a Potential Therapeutic Target for Coronaviruses and Alphaviruses.保守的大分子结构域是冠状病毒和甲病毒的潜在治疗靶点。
Pathogens. 2022 Jan 14;11(1):94. doi: 10.3390/pathogens11010094.
3
Potential therapeutic options for COVID-19: an update on current evidence.
Identification of a series of pyrrolo-pyrimidine-based SARS-CoV-2 Mac1 inhibitors that repress coronavirus replication.
一系列基于吡咯并嘧啶的抑制新冠病毒复制的SARS-CoV-2 Mac1抑制剂的鉴定。
mBio. 2025 Jun 11;16(6):e0386524. doi: 10.1128/mbio.03865-24. Epub 2025 May 23.
4
Derivatives of MOPS: promising scaffolds for SARS coronaviruses Macro domain-targeted inhibition.MOPS的衍生物:用于严重急性呼吸综合征冠状病毒宏结构域靶向抑制的有前景的支架。
FEBS J. 2025 Jun;292(11):2865-2881. doi: 10.1111/febs.70039. Epub 2025 Mar 11.
5
Interferon-induced ADP-ribosylation: technical developments driving ICAB discovery.干扰素诱导的ADP核糖基化:推动ICAB发现的技术进展
Biosci Rep. 2025 Mar 14;45(3):BSR20240986. doi: 10.1042/BSR20240986.
6
Identification of a series of pyrrolo-pyrimidine based SARS-CoV-2 Mac1 inhibitors that repress coronavirus replication.一系列基于吡咯并嘧啶的抑制新冠病毒复制的SARS-CoV-2 Mac1抑制剂的鉴定。
bioRxiv. 2024 Oct 29:2024.10.28.620664. doi: 10.1101/2024.10.28.620664.
7
Extensive exploration of structure activity relationships for the SARS-CoV-2 macrodomain from shape-based fragment merging and active learning.基于形状的片段合并和主动学习对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)宏观结构域的构效关系进行广泛探索。
bioRxiv. 2024 Aug 26:2024.08.25.609621. doi: 10.1101/2024.08.25.609621.
8
HTRF-based assay for detection of mono-ADP-ribosyl hydrolyzing macrodomains and inhibitor screening.基于均相时间分辨荧光共振能量转移(HTRF)的单磷酸腺苷核糖水解宏观结构域检测及抑制剂筛选分析方法
iScience. 2024 Jun 20;27(7):110333. doi: 10.1016/j.isci.2024.110333. eCollection 2024 Jul 19.
9
Synthesis of Structural ADP-Ribose Analogues as Inhibitors for SARS-CoV-2 Macrodomain 1.结构型 ADP-核糖类似物的合成及其作为 SARS-CoV-2 宏结构域 1 抑制剂的应用
Org Lett. 2024 Jul 12;26(27):5700-5704. doi: 10.1021/acs.orglett.4c01792. Epub 2024 Jun 27.
10
GS-441524-Diphosphate-Ribose Derivatives as Nanomolar Binders and Fluorescence Polarization Tracers for SARS-CoV-2 and Other Viral Macrodomains.二磷酸核糖基 GS-441524 衍生物作为 SARS-CoV-2 和其他病毒大结构域的纳摩尔结合物和荧光偏振示踪剂。
ACS Chem Biol. 2024 May 17;19(5):1093-1105. doi: 10.1021/acschembio.4c00027. Epub 2024 Apr 22.
针对 COVID-19 的潜在治疗选择:当前证据的更新。
Eur J Med Res. 2022 Jan 13;27(1):6. doi: 10.1186/s40001-021-00626-3.
4
High-Throughput Activity Assay for Screening Inhibitors of the SARS-CoV-2 Mac1 Macrodomain.高通量活性分析筛选 SARS-CoV-2 Mac1 结构域抑制剂。
ACS Chem Biol. 2022 Jan 21;17(1):17-23. doi: 10.1021/acschembio.1c00721. Epub 2021 Dec 14.
5
Assay technologies facilitating drug discovery for ADP-ribosyl writers, readers and erasers.促进 ADP-ribosyl 书写器、读取器和橡皮擦药物发现的分析技术。
Bioessays. 2022 Jan;44(1):e2100240. doi: 10.1002/bies.202100240. Epub 2021 Nov 23.
6
A molecular toolbox for ADP-ribosyl binding proteins.ADP-核糖基结合蛋白的分子工具包。
Cell Rep Methods. 2021 Dec 20;1(8):100121. doi: 10.1016/j.crmeth.2021.100121. Epub 2021 Nov 11.
7
The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling.SARS-CoV-2 Nsp3 宏结构域逆转干扰素信号诱导的 PARP9/DTX3L 依赖性 ADP-核糖基化。
J Biol Chem. 2021 Sep;297(3):101041. doi: 10.1016/j.jbc.2021.101041. Epub 2021 Aug 4.
8
Unique Mutations in the Murine Hepatitis Virus Macrodomain Differentially Attenuate Virus Replication, Indicating Multiple Roles for the Macrodomain in Coronavirus Replication.鼠肝炎病毒宏结构域中的独特突变可不同程度地减弱病毒复制,表明宏结构域在冠状病毒复制中具有多种作用。
J Virol. 2021 Jul 12;95(15):e0076621. doi: 10.1128/JVI.00766-21.
9
Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking.通过晶体筛选和计算对接鉴定到 SARS-CoV-2 的 Nsp3 结构域的片段结合。
Sci Adv. 2021 Apr 14;7(16). doi: 10.1126/sciadv.abf8711. Print 2021 Apr.
10
The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase.SARS-CoV-2 保守宏结构域是一种单 ADP-核糖基水解酶。
J Virol. 2021 Jan 13;95(3). doi: 10.1128/JVI.01969-20.